Edition:
United States

Mayne Pharma Group Ltd (MYX.AX)

MYX.AX on Australia Stock Exchange

1.35AUD
28 Apr 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.35
Open
$1.35
Day's High
$1.35
Day's Low
$1.30
Volume
5,458,527
Avg. Vol
8,797,165
52-wk High
$2.11
52-wk Low
$1.08

MYX.AX

Chart for MYX.AX

About

Mayne Pharma Group Limited is a specialty pharmaceutical company, which focuses on applying its drug delivery capability to commercialize branded and generic pharmaceuticals. The Company also provides contract development and manufacturing services. It operates in four segments: Generic Products (GPD), Specialty Brands (SBD),... (more)

Overall

Beta: 1.06
Market Cap(Mil.): $2,026.32
Shares Outstanding(Mil.): 1,506.56
Dividend: --
Yield (%): --

Financials

  MYX.AX Industry Sector
P/E (TTM): 18.86 29.39 30.30
EPS (TTM): 0.07 -- --
ROI: 8.05 13.71 13.24
ROE: 10.69 14.66 14.40

BRIEF-Mayne Pharma Group appoints Nick Freeman as new group CFO

* Mayne pharma appoints new group cfo and company secretary-myx.ax

Mar 08 2017

BRIEF-Mayne Pharma executes license and supply agreement for generic Nuvaring® in US

* Mayne Pharma executes license and supply agreement for Generic Nuvaring® in US

Feb 27 2017

BRIEF-Mayne Pharma Group HY revenue $294.8mln, up 132% on 1hfy16

* Hy reported net profit after tax of $72.7m, up 278% Source text for Eikon: Further company coverage:

Feb 23 2017

BRIEF-Mayne Pharma launches butalbital acetaminophen tablets in the U.S.

* Mayne Pharma launches butalbital acetaminophen tablets in united states Source text for Eikon: Further company coverage:

Feb 15 2017

U.S. states sue Mylan, Teva, others for fixing drug prices

WASHINGTON Two years after high generic drug prices became a public controversy, legal cases are starting to land.

Dec 15 2016

BRIEF-Mayne Pharma Group updates on legal proceedings

* Continues to believe these investigations will not have a material impact on its future earnings

Nov 03 2016

BRIEF-IDT Australia ships first Generic Temozolomide Capsules to USA

* Shipped first of its new proprietary generic pharmaceutical products to its us distribution partner, Mayne Pharma Group Source text for Eikon: Further company coverage:

Nov 01 2016

More From Around the Web

Earnings vs. Estimates